Literature DB >> 26726726

Homocysteine--is it still an important risk factor for cardiovascular disease?

Barbara Cybulska1, Longina Kłosiewicz-Latoszek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26726726     DOI： 10.5603/KP.2015.0229

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN： 0022-9032            Impact factor:   3.108


× No keyword cloud information.
  4 in total

Review 1.  Homocysteine-lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Mark Dayer
Journal:  Cochrane Database Syst Rev       Date:  2017-08-17

2.  Association of total homocysteine with blood pressure in a general population of Chinese adults: a cross-sectional study in Jiangsu province, China.

Authors:  Hongxu Wu; Binyan Wang; Xianhui Qin; Xiping Xu; Qianyun Ban; Lulu Chen; Dong Yan; Yaren Yu; Yun Song; Chengzhang Liu; Jingjing Cao; Jingping Zhang; Yuanyuan Zhang; Tao Zhang; Hao Zhang; Huiyuan Guo; Genfu Tang; Yan Zhang; Jianping Li; Yong Huo; Tonghua Zang
Journal:  BMJ Open       Date:  2018-06-19       Impact factor: 2.692

3.  A prospective cohort study of MTHFR C677T gene polymorphism and its influence on the therapeutic effect of homocysteine in stroke patients with hyperhomocysteinemia.

Authors:  Xiaoxia Du; Lin Xiao; Rong Sun; Kunpeng Li; Lin Liang; Luping Song; Zhizhong Liu
Journal:  BMC Neurol       Date:  2020-04-11       Impact factor: 2.474

4.  Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus.

Authors:  Mitra Niafar; Leili Pourafkari; Kavus Shahsavarinia; Nushin Milanchian; Farhad Niafar; Nader D Nader
Journal:  J Cardiovasc Thorac Res       Date:  2016-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.